Antibiotic Treatment for Pneumonia in Long-Term Care Facilities
Introduction to Antibiotic Selection
- The British Thoracic Society recommends amoxicillin-clavulanate as an appropriate oral antibiotic for patients with pneumonia in long-term care facilities, particularly when beta-lactamase producing organisms are a concern 1
- For non-severe community-acquired pneumonia requiring hospitalization or treatment in long-term care facilities, oral antibiotics are generally sufficient and appropriate for most patients, as suggested by the British Thoracic Society 1, 2
Assessment and Treatment
- Before starting oral Augmentin, it is essential to confirm the patient can safely take oral medications, assess vital signs, and consider obtaining a chest radiograph to confirm the diagnosis, as recommended by the British Thoracic Society 1, 2, 6
- Patients with community-acquired pneumonia should be treated for a minimum of 5 days, and treatment should continue until the patient has been afebrile for 48-72 hours and has no more than one pneumonia-associated sign of clinical instability, according to the Infectious Diseases Society of America 3
- Clinical reassessment should occur at 48 hours or earlier if clinically indicated, as suggested by the British Thoracic Society 2
Special Considerations
- Oral Augmentin would be inappropriate in scenarios such as patients with severe pneumonia requiring ICU admission, hemodynamic instability, inability to tolerate oral medications, severe respiratory distress, or high risk for multidrug-resistant organisms, as indicated by the Infectious Diseases Society of America and the British Thoracic Society 2, 3, 4, 5
- Delaying antibiotic administration can increase mortality; therefore, treatment should be initiated promptly after diagnosis, as emphasized by the Infectious Diseases Society of America 3